“���������������������������:za33���24������ ������������������������ ������”的搜索结果，显示 21-30 项，共有 910 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...

2. 肾病和高血压- 临床试验- 妙佑医疗国际

   Rochester, Minn. You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Go to page 2424 · Go to page 2525 · Go to page 2626 · NextNext Page · 申请预约 · 专长与排名研究. Dec. 24, 2024. 妙佑医疗国际明尼苏达州罗切斯特院区、妙佑医疗国际 ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

6. 妇产科- 临床试验- 妙佑医疗国际

   ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Prospective Identification of Long QT Syndrome in Fetal Life. Rochester, Minn. The ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has ...

8. Ratio of 25OHD-to-2425OH2D A new test to confirm 24-hydroxylase CYP24A1 deficiency as the cause of hypercalcemia - 妙佑医疗国际

   Ratio of 25OHD-to-2425OH2D A new test to confirm 24-hydroxylase CYP24A1 deficiency as the cause of hypercalcemia. MAC-20430939.

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Go to page 2424 · Go to page 2525 · Go to page 2626 · NextNext Page · 申请预约 · 专长与排名研究. Dec. 24, 2024. 妙佑医疗国际明尼苏达州罗切斯特院区、妙佑医疗国际 ...